119th Congress · introduced in the House · May 14, 2026
Lainie Jones Comprehensive Cancer Survivorship Act of 2026
Official title from Congress.gov
Latest action (May 14, 2026): Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, and Education and Workforce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
View on Congress.govPolicy area: Health
No official summary has been published for this bill.
Includes amendment, cloture, and procedural votes. Each is labeled with its exact question; only a passage question is a vote to pass the bill.
No recorded roll calls on this bill in coverage.
Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, and Education and Workforce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, and Education and Workforce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, and Education and Workforce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Introduced in House
Introduced in House
Actions from Congress.gov, newest first.
LD-2 reports whose issue descriptions explicitly cite this bill (bill type and number validated against Congress.gov records). A citation does not establish the client's position or any contact with a member.
Loading lobbying reportsCoverage: reports for 2025 onward, posted Jan 1, 2025 through Oct 23, 2026.
21 citations.
AMERICAN LUNG ASSOCIATION · lobbying firm or registrant: AMERICAN LUNG ASSOCIATION
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 20, 2026 · issue area: Medicare/Medicaid
$70,000
Spent on own lobbying
…21 Lung Cancer Medicare Access to Precise Testing Act; HR 6320 Improving Medicaid Precision and Cancer Test Act of 2025; Consolidated Appropriations Act, 2026; HR 8839, Lanie Jones Comprehensive Cancer Survivorship Act of 2026; S. 4566, Increasing Access to Lung Cancer Screening Act; S. 5428, Stop the Wait Act of 2026
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC · lobbying firm or registrant: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 19, 2026 · issue area: Health Issues
$1,790,000
Spent on own lobbying
…y, ACS CAN is working to include funding for palliative care research in the FY26 LHHS Appropriations bill. Lainie Jones Comprehensive Cancer Survivorship Act, H.R. 8839, S.5052. The bill would create pathways to address the financial challenges of cancer survivorship and maintain patients access to the health services needed t…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
SUSAN G. KOMEN · lobbying firm or registrant: ARTEMIS POLICY GROUP LLC
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 19, 2026 · issue area: Medicare/Medicaid
$40,000
Paid to lobbying firm
…ntation Preserving and expanding access to Medicaid Implementation of H.R. 1, One Big Beautiful Bill Act H.R. 2048, Metastatic Breast Cancer Access to Care Act H.R.8839 - Lainie Jones Comprehensive Cancer Survivorship Act of 2026 Personalized Risk Evaluation For Effective Risk Reduction and Early Detection Screening Act (S. 52…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
NATIONAL COALITION FOR CANCER SURVIVORSHIP · lobbying firm or registrant: NATIONAL COALITION FOR CANCER SURVIVORSHIP
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 19, 2026 · issue area: Health Issues
Amount not reported
Provide input regarding contents and legislative strategy related to Lainie Jones Comprehensive Cancer Survivorship Act, HR 8839/S 5052, introduced in 119th Congress.
Congress stated in the filing; bill number and the title cited with it match Congress.gov records, and the bill predates the report. View filing
NATIONAL COALITION FOR CANCER SURVIVORSHIP · lobbying firm or registrant: TURNER & GOSS LLP
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 18, 2026 · issue area: Health Issues
Amount not reported
Lainie Jones Comprehensive Cancer Survivorship Act, HR 8839/S 5052
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. View filing
LYMPHOMA RESEARCH FOUNDATION · lobbying firm or registrant: TURNER & GOSS LLP
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 18, 2026 · issue area: Health Issues
Amount not reported
Lainie Jones Comprehensive Cancer Survivorship Act, HR 8839/S 5052
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. View filing
HADASSAH, THE WOMEN'S ZIONIST ORGANIZATION OF AMERICA, INC. · lobbying firm or registrant: HADASSAH, THE WOMEN'S ZIONIST ORGANIZATION OF AMERICA, INC.
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 15, 2026 · issue area: Health Issues
$60,000
Spent on own lobbying
…IMPROVE Act All provisions This bill instructs the director of the National Institutes of Health (NIH) to advance research to improve maternal health outcomes. H.R. 8839/S.502 - Lainie Jones Comprehensive Cancer Survivorship Act All provisions This bill addresses gaps in the full continuum of cancer care, including the transiti…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
ASSOCIATION FOR CLINICAL ONCOLOGY · lobbying firm or registrant: ASSOCIATION FOR CLINICAL ONCOLOGY
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 15, 2026 · issue area: Health Issues
$80,000
Spent on own lobbying
…d research in palliative and hospice care, with targeted funding and statutory changes to improve care for patients with serious or life-threatening illnesses. H.R. 8839/S. 5052: Lainie Jones Comprehensive Cancer Survivorship Act of 2026 to address the health of cancer survivors.
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
CHILDREN'S CAUSE FOR CANCER · lobbying firm or registrant: I STREET ADVOCATES
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 6, 2026 · issue area: Health Issues
$10,000
Paid to lobbying firm
S. 705, The Innovation in Pediatric Drugs Act; Medicaid coverage for pediatric cancer, HR 8839, The Lainie Jones Comprehensive Cancer Survivorship Act; S.4717, The Asal Sayas National Strategy on Young Adult Cancers Act
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
NATIONAL COALITION FOR CANCER SURVIVORSHIP · lobbying firm or registrant: NATIONAL COALITION FOR CANCER SURVIVORSHIP
2026 Q2 report (Apr 1, 2026 – Jun 30, 2026) · posted Jul 24, 2026 · issue area: Health Issues
Amount not reported
Provide input regarding contents and legislative strategy related to Lainie Jones Comprehensive Cancer Survivorship Act, HR 8839, introduced in 119th Congress.
Congress stated in the filing; bill number and the title cited with it match Congress.gov records, and the bill predates the report. View filing
THE SUSAN G. KOMEN BREAST CANCER FOUNDATION, INC. DBA SUSAN G. KOMEN · lobbying firm or registrant: THE SUSAN G. KOMEN BREAST CANCER FOUNDATION, INC. DBA SUSAN G. KOMEN
2026 Q2 report (Apr 1, 2026 – Jun 30, 2026) · posted Jul 21, 2026 · issue area: Health Issues
$130,000
Spent on own lobbying
…mend title 39, United States Code, to extend the authority of the United States Postal Service to issue a semipostal to raise funds for breast cancer research. H.R.8839 - Lainie Jones Comprehensive Cancer Survivorship Act of 2026; a bill to address the health of cancer survivors and unmet needs that survivors face through the…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
ASSOCIATION OF CANCER CARE CENTERS (FKA ASSOCIATION OF COMMUNITY CANCER CENTERS) · lobbying firm or registrant: ASSOCIATION OF CANCER CARE CENTERS (FKA ASSOCIATION OF COMMUNITY CANCER CENTERS)
2026 Q2 report (Apr 1, 2026 – Jun 30, 2026) · posted Jul 20, 2026 · issue area: Health Issues
$10,000
Spent on own lobbying
…r NIH funding; 21) Supportive cancer care, including discussion of federal legislation, such as the Lainie Jones Comprehensive Cancer Survivorship Act of 2026 (HR 8839)(not yet ACCC endorsed); 22) Clinical Trial Modernization Act (HR 3521/S. 4440); 23) 340B program.
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
HADASSAH, THE WOMEN'S ZIONIST ORGANIZATION OF AMERICA, INC. · lobbying firm or registrant: HADASSAH, THE WOMEN'S ZIONIST ORGANIZATION OF AMERICA, INC.
2026 Q2 report (Apr 1, 2026 – Jun 30, 2026) · posted Jul 20, 2026 · issue area: Health Issues
$60,000
Spent on own lobbying
…IMPROVE Act All provisions This bill instructs the director of the National Institutes of Health (NIH) to advance research to improve maternal health outcomes. H.R. 8839 - Lainie Jones Comprehensive Cancer Survivorship Act All provisions This bill addresses gaps in the full continuum of cancer care, including the transition to…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
SUSAN G. KOMEN · lobbying firm or registrant: ARTEMIS POLICY GROUP LLC
2026 Q2 report (Apr 1, 2026 – Jun 30, 2026) · posted Jul 20, 2026 · issue area: Medicare/Medicaid
$40,000
Paid to lobbying firm
…ntation Preserving and expanding access to Medicaid Implementation of H.R. 1, One Big Beautiful Bill Act H.R. 2048, Metastatic Breast Cancer Access to Care Act H.R.8839 - Lainie Jones Comprehensive Cancer Survivorship Act of 2026 Policies related to the operations of pharmacy benefits managers: comments on proposed rules re PB…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
AMERICAN LUNG ASSOCIATION · lobbying firm or registrant: AMERICAN LUNG ASSOCIATION
2026 Q2 report (Apr 1, 2026 – Jun 30, 2026) · posted Jul 20, 2026 · issue area: Medicare/Medicaid
$120,000
Spent on own lobbying
…21 Lung Cancer Medicare Access to Precise Testing Act; HR 6320 Improving Medicaid Precision and Cancer Test Act of 2025; Consolidated Appropriations Act, 2026; HR 8839, Lanie Jones Comprehensive Cancer Survivorship Act of 2026; S. 4566, Increasing Access to Lung Cancer Screening Act
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC · lobbying firm or registrant: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.
2026 Q2 report (Apr 1, 2026 – Jun 30, 2026) · posted Jul 20, 2026 · issue area: Health Issues
$1,240,000
Spent on own lobbying
…y, ACS CAN is working to include funding for palliative care research in the FY26 LHHS Appropriations bill. Lainie Jones Comprehensive Cancer Survivorship Act, H.R. 8839. The bill would create pathways to address the financial challenges of cancer survivorship and maintain patients access to the health services needed to addres…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
LYMPHOMA RESEARCH FOUNDATION · lobbying firm or registrant: TURNER & GOSS LLP
2026 Q2 report (Apr 1, 2026 – Jun 30, 2026) · posted Jul 19, 2026 · issue area: Health Issues
Amount not reported
Lainie Jones Comprehensive Cancer Survivorship Act, HR 8839
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. View filing
NATIONAL COALITION FOR CANCER SURVIVORSHIP · lobbying firm or registrant: TURNER & GOSS LLP
2026 Q2 report (Apr 1, 2026 – Jun 30, 2026) · posted Jul 19, 2026 · issue area: Health Issues
Amount not reported
Lainie Jones Comprehensive Cancer Survivorship Act, HR 8839
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. View filing
STUPID CANCER · lobbying firm or registrant: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2026 Q2 report (Apr 1, 2026 – Jun 30, 2026) · posted Jul 17, 2026 · issue area: Health Issues
$10,000
Paid to lobbying firm
Lainie Jones Comprehensive Cancer Survivorship Act (CCSA) H.R. 8839
Congress inferred from the report year; bill number matches Congress.gov records and the bill predates the report; no title was cited with it. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
ASSOCIATION FOR CLINICAL ONCOLOGY · lobbying firm or registrant: ASSOCIATION FOR CLINICAL ONCOLOGY
2026 Q2 report (Apr 1, 2026 – Jun 30, 2026) · posted Jul 16, 2026 · issue area: Health Issues
$480,000
Spent on own lobbying
…d research in palliative and hospice care, with targeted funding and statutory changes to improve care for patients with serious or life-threatening illnesses. H.R. 8839: Lainie Jones Comprehensive Cancer Survivorship Act of 2026 to address the health of cancer survivors.
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
CHILDREN'S CAUSE FOR CANCER · lobbying firm or registrant: I STREET ADVOCATES
2026 Q2 report (Apr 1, 2026 – Jun 30, 2026) · posted Jul 9, 2026 · issue area: Health Issues
$10,000
Paid to lobbying firm
S. 705, The Innovation in Pediatric Drugs Act; survivorship in pediatric cancer, Medicaid coverage for pediatric cancer, HR 8839, The Lainie Jones Comprehensive Cancer Survivorship Act
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing